C. Smith

Imaging β-amyloid burden in aging and dementia

C. Rowe, W. Klunk, C. Masters, 2007, Neurology.

Galantamine-induced improvements in cognitive function are not related to alterations in α4β2 nicotinic receptors in early Alzheimer’s disease as measured in vivo by 2-[18F]Fluoro-A-85380 PET

G. Savage, P. Nathan, K. Wesnes, 2008, Psychopharmacology.

Synaptic resilience is associated with maintained cognition during ageing

I. Deary, I. Deary, J. Tulloch, 2022, medRxiv.

Synaptic oligomeric tau in Alzheimer’s disease — A potential culprit in the spread of tau pathology through the brain

J. Tulloch, Colin Smith, A. Lleó, 2023, Neuron.